Компания Radnostix приобрела технологии платформы LARA System для развития радиомедицины

Radnostix, Inc. (INIS), a radio-pharmaceutical company, announced the closing of its acquisition of the LARA System technology platform, ELLEXA Explorer software, and associated intellectual property (IP) from Lucerno Dynamics, LLC. Financial terms of the transaction were not disclosed. The acquisition enables Radnostix to leverage the acquired technology to develop new product offerings for radiopharmaceutical and nuclear medicine applications, particularly in drug delivery and real-time monitoring. Shahe Bagerdjian, CEO of Radnostix, said the acquisition is expected to strengthen the company's medical device portfolio and support the development of solutions for Radioligand Therapy (RLT) administration clinics. INIS closed Tuesday's trade at $0.07 on the OTC Markets. For comments and feedback contact: [email protected] Business News July 13, 2026 10:12 ET The week saw the release of the minutes of the Federal Reserve’s latest monetary policy session, foreign trade figures and survey data on manufacturing and services in the U.S. External trade data from Germany was the highlight in Europe, while the latest macroeconomic projections from the Asian Development Bank and the International Monetary Fund gained attention.